These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 3rd communication: effect on postischemic cerebral blood flow and metabolism, and ischemic neuronal cell death. Szabo L; Hofmann HP Arzneimittelforschung; 1989 Mar; 39(3):314-9. PubMed ID: 2757657 [TBL] [Abstract][Full Text] [Related]
6. Calcium antagonists in the treatment of experimental cerebral ischemia. Ginsberg MD; Lin B; Morikawa E; Dietrich WD; Busto R; Globus MY Arzneimittelforschung; 1991 Mar; 41(3A):334-7. PubMed ID: 1859503 [TBL] [Abstract][Full Text] [Related]
7. Effects of emopamil on postischemic blood flow and neuronal damage in rat brain. Bielenberg GW; Sauer D; Nuglisch J; Beck T; Rossberg C; Mennel HD; Krieglstein J Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):230-5. PubMed ID: 2725698 [TBL] [Abstract][Full Text] [Related]
8. Intraischemic but not postischemic brain hypothermia protects chronically following global forebrain ischemia in rats. Dietrich WD; Busto R; Alonso O; Globus MY; Ginsberg MD J Cereb Blood Flow Metab; 1993 Jul; 13(4):541-9. PubMed ID: 8314910 [TBL] [Abstract][Full Text] [Related]
10. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 2nd communication: brain penetration, cerebral vascular and metabolic effects. Szabo L Arzneimittelforschung; 1989 Mar; 39(3):309-14. PubMed ID: 2757656 [TBL] [Abstract][Full Text] [Related]
11. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 1st communication: pharmacological profile. Hofmann HP; Raschack M; Unger L Arzneimittelforschung; 1989 Mar; 39(3):304-8. PubMed ID: 2757655 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a novel calcium channel blocker, (S)-emopamil, on regional cerebral edema and neurobehavioral function after experimental brain injury. Okiyama K; Smith DH; Thomas MJ; McIntosh TK J Neurosurg; 1992 Oct; 77(4):607-15. PubMed ID: 1527621 [TBL] [Abstract][Full Text] [Related]
13. Effect of S-emopamil, nimodipine, and mild hypothermia on hippocampal glutamate concentrations after repeated cerebral ischemia in rabbits. Matsumoto M; Scheller MS; Zornow MH; Strnat MA Stroke; 1993 Aug; 24(8):1228-34. PubMed ID: 8102022 [TBL] [Abstract][Full Text] [Related]
14. Effect of lidocaine on forebrain ischemia in rats. Sutherland G; Ong BY; Louw D; Sima AA Stroke; 1989 Jan; 20(1):119-22. PubMed ID: 2911825 [TBL] [Abstract][Full Text] [Related]
15. Differential inhibition of neuronal calcium entry and [3H]-D-aspartate release by the quaternary derivatives of verapamil and emopamil. Keith RA; Mangano TJ; DeFeo PA; Ernst GE; Warawa EJ Br J Pharmacol; 1994 Oct; 113(2):379-84. PubMed ID: 7834187 [TBL] [Abstract][Full Text] [Related]
16. Hyperthermia delayed by 24 hours aggravates neuronal damage in rat hippocampus following global ischemia. Baena RC; Busto R; Dietrich WD; Globus MY; Ginsberg MD Neurology; 1997 Mar; 48(3):768-73. PubMed ID: 9065563 [TBL] [Abstract][Full Text] [Related]
17. Effects of calcium entry blocker emopamil on postischemic energy metabolism of the isolated perfused rat brain. Bielenberg GW; Haubruck H; Krieglstein J J Cereb Blood Flow Metab; 1987 Aug; 7(4):489-96. PubMed ID: 3611207 [TBL] [Abstract][Full Text] [Related]
18. The effect of calcium entry blocker S-emopamil on cerebrocortical metabolism and blood flow changes evoked by graded hypotension. Kovách AG; Nguyen LT; Pék L; Dezsi L; Lohinai ZS Adv Exp Med Biol; 1989; 248():461-70. PubMed ID: 2782166 [TBL] [Abstract][Full Text] [Related]
19. The effects of caffeine on ischemic neuronal injury as determined by magnetic resonance imaging and histopathology. Sutherland GR; Peeling J; Lesiuk HJ; Brownstone RM; Rydzy M; Saunders JK; Geiger JD Neuroscience; 1991; 42(1):171-82. PubMed ID: 1861772 [TBL] [Abstract][Full Text] [Related]
20. Protection with lubeluzole against delayed ischemic brain damage in rats. A quantitative histopathologic study. Haseldonckx M; Van Reempts J; Van de Ven M; Wouters L; Borgers M Stroke; 1997 Feb; 28(2):428-32. PubMed ID: 9040701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]